Andrew B. Nixon

HDAC6 is a microtubule-associated deacetylase

Charlotte Hubbert, Amaris R. Guardiola, Rong Shao et al. · Nature · 2002 · 2.4K citations

Life Sciences, Biochemistry, Molecular Biology +5

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

Takuya Osada, Gabriel T. Chong, Robert L. Tansik et al. · Cancer Immunology Immunotherapy · 2008 · 310 citations · Full text

Medicine, Immunology, Oncology +17

Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression

Carie Facemire, Andrew B. Nixon, Robert Griffiths et al. · Hypertension · 2009 · 279 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Balamayoora Theivanthiran, Kathy S. Evans, Nicholas C. DeVito et al. · Journal of Clinical Investigation · 2020 · 250 citations · Full text

Life Sciences, Immunology, Oncology +17

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Erika J. Lampert, Alexandra S. Zimmer, Michelle R. Padget et al. · Clinical Cancer Research · 2020 · 221 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17